Vimarsana
Biggest News Aggregation in the World

Page 27 - Immunic Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Inc Today - Breaking & Trending Today

EQS-News: Immunic Reports New Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis Supporting the Drug's Neuroprotective Potential - Vimarsana News

EQS-News: Immunic Reports New Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis Supporting the Drug's Neuroprotective Potential

Issuer: Immunic, Inc. / Key word(s): Study results/Conference Immunic Reports New Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis Supporting the Drug’s Neuroprotective Potential 17.11.2022 / 12:30 CET/CEST The issuer is solely responsible for th...

EQS-News: Immunic to Participate in Investor and Scientific Conferences in November and December - Vimarsana News

EQS-News: Immunic to Participate in Investor and Scientific Conferences in November and December

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Investor and Scientific Conferences in November and December 10.11.2022 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Investor and Scientific Conferences ...

Immunic to Participate in Investor and Scientific Conferences in November and December - Vimarsana News

Immunic to Participate in Investor and Scientific Conferences in November and December

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...

EQS-News: Immunic, Inc.: Immunic to Participate in Investor and Scientific Conferences in November and December - Vimarsana News

EQS-News: Immunic, Inc.: Immunic to Participate in Investor and Scientific Conferences in November and December

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Investor and Scientific Conferences in November and December 10.11.2022 / 12:30 CET/CEST The issuer is solely

Immunic, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update - Vimarsana News

Immunic, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...